It's Becker Awareness Week (Oct 6 - Oct 13)! Join us in raising awareness about Becker Muscular Dystrophy (BMD) and making a difference. "Every day, we follow science to bring the potential of muscle-targeted therapeutics to the communities we serve." - Joanne Donovan, M.D., Ph.D., Chief Medical Officer
Edgewise Therapeutics的动态
最相关的动态
-
???Sunshine & Support: June is #Scleroderma Awareness Month!???? Join the summer fun as we raise awareness for scleroderma and its impact on thousands worldwide. At MLM Medical Labs, we're not just soaking up the sun this summer; we're shining a light on our preclinical dermal models, helping pharma and biotech companies develop treatments to combat this challenging autoimmune disease. Just like protecting your skin from those UV rays, let's work together to shield and support those affected by scleroderma. Together, under the sun, we can make a real difference! #SclerodermaAwarenessMonth?#Scleroderma #PreclinicalDiseaseModels #DermalModels
要查看或添加评论,请登录
-
-
“I’m a smart man but I’m not a doctor. You need to explain things to me in a common language.” – Ignacio Edenburg, #MF patient, member MPNRF Patient Impact Council? Empowering patients at every stage of the R&D lifecycle bring increased impact. But it won’t have effects on patients’ daily lives if they don’t understand what the research shows and its implications. A care team is honoring the quality of life and future of their patients by explaining updates in MPN symptom management, NCCN Guidelines (National Comprehensive Cancer Network), newly published research, and new or emerging therapies. The patient can then be a true partner in their care, making informed decisions and feeling empowered in their journey.? Industry & research professionals, how can we simplify complex terms for better patient dialogue? Share your insights below.? [ Join our network: https://mpnrf.info/3SRq8h2 ]
要查看或添加评论,请登录
-
Join us on August 6th @ 11am EST for groundbreaking tools and methodologies for generation of functional, scaleable 2D and 3D co-culture models of the human brain!! #brain #3Dcellmodels #diseaseresearch #drugdiscovery #InventiaLifeScience
????? Save the date for a webinar with SelectScience? on August 6th at 11AM EST! Join Dr. William Bernard and Dr. Martin Engel in our upcoming webinar as they reveal groundbreaking tools and methodologies for the generation of functional, scalable 2D and 3D co-culture models of the human brain for disease research and drug discovery. Don’t miss out on accelerating your drug discovery timelines! Reserve your spot now and receive a certificate of attendance. REGISTER: https://lnkd.in/e2mSA2Pz
要查看或添加评论,请登录
-
-
Facilitator/Consultant/Coach ... ABC, CFRM, CLS, CCMT, CTM, GRI, NSA ... Sharpening your advantage by maximizing organizational capacity through individual leadership development
Congratulations, Therese Eutsler, PT II, CMTPT/DN, CCT, LHD, on completing MedBridge professional development course “Immunotherapy: What Every Rehab Professional Should Know.” The course’s learning objectives and goals: * Identify the use of immunotherapy in the oncologic patient populations * Identify the different types of immunotherapy, their indications, and their administration methods, * Recall common side effects of immunotherapy * Recognize how immunotherapy may affect and person’s functional mobility
要查看或添加评论,请登录
-
-
Creative B2B marketing, communications and branding. Trend scout at the intersection of industry and design.
CENTOGENE's multiomic data insights support the end-to-end Pharma drug development workflow across all disease areas, especially rare and neurodegenerative. Learn how we support real-world evidence & registries for Fabry Disease with LaTina Green at the FSIG Expert Fabry Conference, and how we accelerate and de-risk clinical trials with Mario D'Alessandro at SCOPE!
Throughout the month of February, the CENTOGENE team is on the road – sharing our latest insights and advancements to accelerate diagnoses and treatment options for rare disease patients. The past days, LaTina Green, Peter Bauer, and Steffen Fischer were at WORLDSymposium, and we can't wait to meet more of you as our team continues their tour throughout the U.S. ???????? ????: ?? Join LaTina Green at the 11th FSIG Expert Fabry Conference, in San Diego, California, on February 9-11 ?? Connect with Mario D'Alessandro at SCOPE 2024, taking place in Orlando, Florida, February 11-14 #Conference #Event #Networking #USA #WORLDSymposium #SCOPEsummit #Fabry #ClinicalTrial #DigitalHealth #RareDiseaseDay #RDD #RareIsMany #ShareYourColours #LightUpForRare #JoiningForces #RareDisease #Patients #Physicians #Pharma
要查看或添加评论,请登录
-
-
Ever wondered what happens before a clinical trial begins? ?? Let's dive in! Before a potential treatment can even think about human trials, it goes through pre-clinical studies – the unsung heroes of medical research. These studies start with experiments on cancer cells and lab animals.? Researchers want to see if the treatment shows promise in fighting the disease. But here's the catch – what works in a lab might not work the same in humans. That's why FDA approval is crucial. Before a clinical trial can start, it has to pass through pre-clinical tests and earn FDA approval.? It's a rigorous journey, but essential for ensuring the safety and effectiveness of treatments. Because when it comes to health, there are no shortcuts.?
要查看或添加评论,请登录
-
-
??More Exciting News from Palatin Technologies! ?? We're thrilled to announce positive results from our Phase 3 PL9643 MELODY-1 clinical trial for Dry Eye Disease, showcased at the ASCRS 2024. ?? Key Highlights: ?? The co-primary symptom endpoint of pain met statistical significance. ??Rapid onset of efficacy was observed within just two weeks. ??Outstanding safety and tolerability profile. These results underscore PL9643's potential in transforming DED treatment and position us at the forefront of ophthalmic innovation. ?? Dive into the full details of our positive phase 3 results here. https://lnkd.in/g3QA4TBF
要查看或添加评论,请登录
-
-
Scary https://lnkd.in/dPxAzpur Cancer is hitting more young people in the U.S. and around the globe, baffling doctors. Doctors said obesity and lifestyle can’t fully account for the plight of the people arriving at their clinics.? as often with cancers, difficult to link it with just one cause Let's hope that with better data collection & analysis combined with prevention & better lifestyle, we can reverse this trend
Cancer Is Striking More Young People, and Doctors Are Alarmed and Baffled
wsj.com
要查看或添加评论,请登录
-
?? Don't forget to check out MedNews Week's?? most recent Keynote Speaker ??Dr. Brian Van Tine?? of Washington University in St. Louis MO, Department of Medicine– as he discusses Translating Metabolic Therapies into Sarcoma. It was a pleasure to learn from him! Event link: https://lnkd.in/g2zC5uR2 ??Accomplishments:? ????Director, Developmental Therapeutics (Phase 1) Sarcoma Program, Alvin J ??Internationally recognized leader in Sarcoma Research and Treatment ??Recipient of Various awards and honors, including but not limited to: - Presented the 2014 Rosenfeld Lecture for the Sarcoma Alliance for Research and Collaboration - First Place Poster, “Loss of Taspase1 Abrogates HER2/neu Induced Breast Cancer, ”Breast Cancer Symposium, Washington University - Physician Scientist Training Program, Washington University ??A passionate and dedicated mentor who has mentored >12 mentees in all stages of training. MedNews Week Team: Yan Leyfman, MD Maduri Balasubramanian Sean Jackewicz Shreevikaa Kannan Soumiya Nadar Rabab Hunaid Abbas Emad Bin Zahid Ahmed Hashim Azeez Vallabhaneni Sree Harshitha Muskan Joshi? Helena Sanchez Coloma Alexandra Van de Kieft Harshal C. Gayathri Pramil Menon Fabiha Amin #SarcomaAwareness #SarcomaSupport #BoneCancer #SoftTissueSarcoma #CancerAwareness #FightSarcoma #CureSarcoma #SarcomaWarrior #SarcomaResearch #RareCancer #SarcomaCommunity #SarcomaSurvivor #SarcomaStrong #EndSarcoma #CancerResearch #SarcomaWarrior #ChildhoodCancer #SarcomaFighter #SarcomaSupportGroup #TogetherAgainstSarcoma #MetabolicTherapy #MetabolicHealth #NutritionalTherapy #KetogenicDiet #IntermittentFasting #MetabolicSyndrome #Biohacking #MitochondrialHealth #MetabolicFlexibility #FastingForHealth #LowCarbLiving #HighFatDiet #MetabolismBoost #NutritionalScience #TherapeuticFasting #NutritionalMetabolism #EnergyMetabolism #NutritionAndHealth #CellularHealth #MetabolicBalance #MetabolicTherapiesForSarcoma #SarcomaMetabolism #MetabolicApproachToSarcoma #SarcomaNutritionalTherapy #MetabolicInterventionsForSarcoma #SarcomaAndKetogenicDiet #MetabolicTreatmentForSarcoma #SarcomaMetabolicHealth #NutritionalStrategiesForSarcoma #SarcomaMetabolicSyndrome #MetabolicSupportForSarcoma #SarcomaAndIntermittentFasting #MetabolicTherapeuticApproach #SarcomaMetabolicFlexibility #MetabolicApproachToCancer #SarcomaBiohacking #MetabolicStrategiesForSarcoma #SarcomaMitochondrialHealth #MetabolicBalanceForSarcoma #SarcomaAndNutritionalMetabolism
MedNews Week - YouTube
youtube.com
要查看或添加评论,请登录
-
Learn more about what the Cystic Fibrosis Foundation and others are doing to support clinical trial progress today on #ClinicalTrialsDay.
On Clinical Trials Day, we celebrate cystic fibrosis research teams and study participants who pave the way for new CF treatments. Clinical trials have led to incredible breakthroughs in the treatment of CF and make living with CF better for thousands of people. Thank you for making a difference!
要查看或添加评论,请登录
-